Patients with sickle cell disease already face suspicion and biases based on their need for opioids, and African American patients also face additional racial biases, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Patients with sickle cell disease already face suspicion and biases based on their need for opioids, and African American patients also face additional racial biases, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Transcript
Sickle cell is a disease that disproportionately affects African Americans—do you think that racial disparity impacts how the disease is treated and how pain is managed?
Yeah, it's a very rare adult with sickle cell disease—as a matter of fact, I don't think I've ever met anyone, and adult with sickle cell disease, who hasn't come to an ED [emergency department] at least once and been accused of being addicted. It's almost a universal experience in our patients.
So, I do suspect that racial biases play a role in that. But, you know, racial bias is built into the DNA of our society and to some extent to their medical system, as well. So, it affects where people live, it affects how their schooling goes, it affects their jobs, and so it's pervasive and it is pervasive. In the medical system too, and then with respect to pain care, we know that African American patients tend to get underevaluated and undertreated. So, you can certainly believe that that happens with sickle cell disease.
And then on top of that, my team and I have traveled to places where providers and patients are typically the same ethnicity. and you see very much the same biases around sickle cell disease itself, which I think again, has to do with the fact that you have severe acute pain with no identifiable signs is treated with opioids. And so, it's just ripe for suspicion. And so, our patients really get hit from all directions.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations
April 22nd 2024Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Read More